Characterization of the gene encoding human sarcolipin (SLN), a proteolipid associated with SERCA1: Absence of structural mutations in five patients with brody disease by Odermatt, A. (Alex) et al.
GENOMICS 45, 541±553 (1997)
ARTICLE NO. GE974967
Characterization of the Gene Encoding Human Sarcolipin (SLN), a
Proteolipid Associated with SERCA1: Absence of Structural
Mutations in Five Patients with Brody Disease
Alex Odermatt,* Peter E. M. Taschner,² Stephen W. Scherer,³ Barbara Beatty,§
Vijay K. Khanna,* David R. Cornblath,Ø Vinay Chaudhry,Ø Won-Chee Yee,H
Bertold Schrank,** George Karpati,²² Martijn H. Breuning,²,³³
Nine Knoers,§§ and David H. MacLennan*,1
*Banting and Best Department of Medical Research, University of Toronto, Charles H. Best Institute, 112 College Street, Toronto,
Ontario, Canada M5G 1L6; ²Department of Human Genetics, Sylvius Laboratories, Leiden University, P.O. Box 9503,
Wassenaarseweg 72, 2300 RA Leiden, The Netherlands; ³Department of Genetics, The Hospital for Sick Children, 555 University
Avenue, Toronto, Ontario, Canada M5G 1X8; §Department of Pathology, University of Toronto, Ontario Cancer Institute,
Princess Margaret Hospital, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9; ØDepartment of Neurology, Johns
Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, Maryland 21205; \Department of
Neurology, Washington University School of Medicine, 660 Euclid, St. Louis, Missouri 63110;
**Neurologische UniversitaÈ tsklinik, Josef-Schneider-Strasse 11, 97080 WuÈ rzburg, Germany;
²²Montreal Neurological Institute, McGill University, 3801 Rue University, Montreal, Quebec,
Canada H3A 2B4; ³³Department of Clinical Genetics, Erasmus University, Dr. Molewaterplein 50,
P.O. Box 1738, 3000 DR Rotterdam, The Netherlands; and §§Department of Human Genetics,
University Hospital Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
Received April 14, 1997; accepted August 7, 1997
ease is an inherited disorder of skeletal muscle func-
tion, characterized by exercise-induced impairment ofSarcolipin (SLN) is a low-molecular-weight protein
that copuri®es with the fast-twitch skeletal muscle muscle relaxation. Mutations in the ATP2A1 gene en-
coding SERCA1 have been associated with the autoso-sarcoplasmic reticulum Ca2/ ATPase (SERCA1). Geno-
mic DNA and cDNA encoding human sarcolipin (SLN) mal recessive inheritance of Brody disease in three
families, but not with autosomal dominant inheritancewere isolated and characterized and the SLN gene was
mapped to chromosome 11q22±q23. Human, rabbit, of the disease. A search for mutations in the SLN gene
in ®ve Brody families, four of which were not linkedand mouse cDNAs encode a protein of 31 amino acids.
Homology of SLN with phospholamban (PLN) suggests to ATP2A1, did not reveal any alterations in coding,
splice junction or promoter sequences. The homozy-that the ®rst 7 hydrophilic amino acids are cyto-
plasmic, the next 19 hydrophobic amino acids form a gous deletion of C438 in the coding sequence of
ATP2A1 in Brody disease family 3, leading to asingle transmembrane helix, and the last 5 hydrophilic
amino acids are lumenal. The cytoplasmic and trans- frameshift and truncation following Pro147 in SERCA1,
is the fourth ATP2A1 mutation to be associated withmembrane sequences are not well conserved among
the three species, but the lumenal sequence is highly autosomal recessive Brody disease. q 1997 Academic Press
conserved. Like SERCA1, SLN is highly expressed in
rabbit fast-twitch skeletal muscle, but it is expressed
to a lower extent in slow-twitch muscle and to an even INTRODUCTION
lower extent in cardiac muscle, where SERCA2a and
PLN are highly expressed. It is expressed in only trace
amounts in pancreas and prostate. SLN and PLN genes Sarcolipin
resemble each other in having two small exons, with
their entire coding sequences lying in exon 2 and a Sarcolipin (SLN) was ®rst isolated as a low-molecu-
large intron separating the two segments. Brody dis- lar-weight proteolipid from rabbit fast-twitch skeletal
muscle sarcoplasmic reticulum and from preparations
of the Ca2/ ATPase (SERCA1) puri®ed from that sourceSequence data from this article have been deposited with the Gen-
Bank/EMBL Data Libraries under Accession Nos. U96091, rabbit (MacLennan et al., 1972). Attempts were made to dis-
cDNA; U96092, U96093, human gDNA; U96094, human cDNA. cover a function for SLN, by reconstitution of the pro-1 To whom correspondence should be addressed. Telephone
teolipid with puri®ed preparations of SERCA1 and(416) 978-5008. Fax: (416) 978-8528. E-mail: david.maclennan@
utoronto.ca. measurement of any alteration in SERCA1 function.
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SLN was reported to enhance the coupling ratio be- Brody families. In later studies, Benders et al. (1994)
were unable to measure a decrease in SERCA1 proteintween Ca2/ uptake and Ca2/-dependent ATP hydroly-
sis when reconstituted with SERCA1, but, when puri- content in skeletal muscle from seven Brody families,
but SERCA1 activity was reduced by 50%.®ed SLN was added to the exterior of these reconstitu-
ted liposomes, Ca2/ accumulation was diminished, We have reported the association of some cases of
Brody disease with the autosomal recessive inheritanceimplying that SLN might act as a Ca2/ ionophore
(Racker and Eytan, 1975). MacLennan et al. (1980) of mutations in the ATP2A1 gene, encoding SERCA1,
in two Brody families (Odermatt et al., 1996), butfractionated SLN away from SERCA1, reconstituted
the highly puri®ed SERCA1 in lipid bilayers, and found ATP2A1 was ruled out as a candidate gene in three
other Brody families in an earlier study (Zhang et al.,no alteration in Ca2//ATP coupling ratios before and
after removal of SLN. Later studies by Maruyama and 1995), demonstrating that the cause of the disease is
heterogeneous. Some of the non-ATP2A1-linked fami-MacLennan (1988) showed that SERCA1 cDNA, ex-
pressed alone in heterologous cell culture, yielded mi- lies were characterized by dominant inheritance of the
disease. Since SERCA1 content was reported to be nor-crosomal membranes containing fully functional Ca2/
uptake and Ca2/-dependent ATPase activities, sug- mal, but with reduced activity in seven Brody patients
studied by Benders et al. (1994), we deduced that agesting that SLN plays no essential role in Ca2/ up-
take. The protein was sequenced by Wawrzynow et al. candidate gene for Brody disease might encode a pro-
tein that would interact with SERCA1 and, when mu-(1992) and named sarcolipin.
In studies of the yeast H/ ATPase, Navarre et al. tated, become a dominant inhibitor of SERCA1 func-
tion. Accordingly, the human SLN gene was evaluated(1992) discovered that two low-molecular-weight pro-
teolipids are associated with this P-type ATPase. In as a candidate gene for Brody disease. Unfortunately,
we were unable to ®nd any alterations in coding, splicedouble mutants, lacking both proteolipids, the Vmax of
the H/ ATPase was reduced to 50% of that of wild junction, or promoter sequences that would support
SLN as a candidate gene for Brody disease in ®ve pa-type strains (Navarre et al., 1994). The mechanism of
interaction of these proteolipids with the H/ ATPase tients.
has not been determined.
Phospholamban (PLN) is a 52-amino-acid protein lo-
MATERIALS AND METHODScated in the sarcoplasmic reticulum of cardiac, slow-
twitch, and smooth muscles, where it acts as an inhibi-
Preparation of RNA and RT-PCR. Total RNA was isolated fromtor of SERCA2 by lowering its apparent af®nity for
normal human skeletal muscle using guanidium±isothiocyanate±Ca2/ (Tada and Katz, 1982). The protein has a hydro- phenol±chloroform extraction (Chomczynski and Sacchi, 1987). A 5-
philic N-terminal sequence of 30 amino acids, which mg aliquot of total RNA was reverse transcribed in 50 ml of a reaction
would alter its solubility by comparison with low-mo- mix (Stratagene cDNA synthesis kit) containing 50 U of MMuLV
reverse transcriptase at 377C in the presence of RNase Block Inhibi-lecular-weight proteolipids, but, in respect to its inter-
tor and 0.5 mg of random primers. Following ®rst-strand cDNA syn-action with a P-type cation pump, it resembles other
thesis, RNA was hydrolyzed by the addition of 50 ml of 0.3 N sodiumproteolipids. hydroxide and 30 mM EDTA and boiling for 5 min. The pH was then
In this paper, we characterize the sarcolipin (SLN) neutralized with 25 ml of Tris±HCl, pH 8.3. After extraction with
phenol and chloroform, the cDNA was precipitated with ethanol andgene and demonstrate structural similarities between
washed, and the pellet was dissolved in 30 ml of H2O. Aliquots of 1the SLN and PLN genes, as well as homology between
ml of ®rst-strand cDNA were used as the template in subsequentthe peptide sequences of their products. SLN gene tran-
PCR ampli®cations.scription is shown to be high in fast-twitch skeletal
PCR cloning of partial SLN cDNA based on known peptide se-muscle, where SERCA1 expression predominates. By quence. Reverse translation of the amino acid sequence of rabbit
contrast, PLN gene transcription was shown earlier to sarcolipin (Wawrzynow et al., 1992) permitted the synthesis of two
fully degenerate oligonucleotide primers, SALF7 and SALR7 (Tablebe high in cardiac muscle, where SERCA2a expression
1), based on the 5* and 3 * ends of the cDNA coding sequence. Thepredominates (Fujii et al., 1988).
oligonucleotide primers also contained nine nucleotide BamHI re-
striction endonuclease sites at their 5* ends to facilitate subsequent
cloning of PCR products. PCR ampli®cation with primers SALF7 andBrody Disease
SALR7 was carried out using either 100 ng of DNA from a full-
length rabbit skeletal muscle cDNA library (MacLennan et al., 1985)Brody disease is an inherited disorder of skeletal
constructed in the pcDX vector (Okayama and Berg, 1983) or, alter-muscle function, characterized by exercise-induced im-
natively, using 1 ml of ®rst-strand cDNA derived from normal humanpairment of muscle relaxation. Studies of the sarcoplas- skeletal muscle as a template. Taq polymerase and Taq Extender
mic reticulum from Brody patients have shown de- (Stratagene) were used for PCR ampli®cation in the buffer supplied.
creased Ca2/ uptake and Ca2/-dependent ATP hydroly- Denaturation was for 1 min at 947C, annealing was at 577C for 2
min, and extension for 30 cycles was at 727C for 2 min, followed bysis. (Brody, 1969; Karpati et al., 1986: Danon et al.,
a ®nal extension at 727C for 10 min. Ampli®ed DNA obtained using1988; Taylor et al., 1988; Wevers et al., 1992; Poels et
either rabbit or human template was cloned into the BamHI siteal., 1993; Benders et al., 1994). In the studies of Karpati of the Bluescript vector BsKs(/) (Stratagene). The coding sequence
et al. (1986), no immunologically reactive ATPase was between degenerate primers was 45 bp long for both the rabbit and
the human SLN genes.observed in fast-twitch ®bers of probands from two
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TABLE 1
Primer Sequence Description
SALF7 5* ACAGGATCCATGGA (AG) (AC) G (ACGT) (AT) (CG) (Degenerated PCR)
(ACGT) AC (ACGT) (AC) G (ACGT) GA (AG) C 3 *
SALR7 5* ACAGGATCCTG (AG) TA (ACGT) (CG) (AT) (ACGT) (Degenerated PCR)
C (GT) (ACGT) AC (ACGT) A (AG) (ACGT) A (AG) CC 3*
SALF9 5* CTTGGATCCGTTGTCCTTATTACAGTGATCC 3 * (Inverse PCR,
SALR9 5* CAAGGATCCACAGTGAAGTTGAGACACAGC 3 * rabbit SLN)
RSAF7 5* TAAGGATCCACACAGCCTGGGAGATGAGCC 3 * (cDNA cloning,
RSAR8 5* TAAGGATCCGTGGTTGACTTAACTTTATTCACATG 3 * rabbit SLN)
RACE1 5* CAGCCTTGACTTGAGCAGTAGCTGAGACTCAAGTCG
TGTTTTTTTTTTTTTTTTTT 3 * (3 * RACE)
RACE3 5* GTTGGATCCAGTAGCTGAGACTCAAGTCGTG 3 * (3 * RACE)
SALF10 5* CAAGGATCCGAGCTGTGTCTCAACTTCAC 3 * (Inverse PCR,
SALR10 5* CAAGGATCCAGGATCACTGTAATAAGGACAAC 3 * human SLN)
HSAF5 5* GTTGGAGCTCAAGTTGGAGACAGCGAG 3 * (cDNA cloning,
HSAR5 5* GTTGAGCTCGTTGACTTAACTTTATTCACATGATAG 3 * human SLN)
HSAF1 5* GTTGGATCCTTGATTACGGTTATTCTTATGTG 3 * (Inverse PCR, human
HSAR1 5* GAAGGATCCACAATAGTGAAGTTGAGAAACAG 3 * 3 * ¯anking gDNA)
HSAF8 5* GATTCTAGAGTCTTTGATCCTCTTCAGGTAACTG 3 * (Inverse PCR, human
HSAR8 5* TACTCTAGACTATGGCAGGTTTCTCCTCGCTG 3 * 5* ¯anking gDNA)
(Primer extension)
HSAF3 5* GTCCTGGGATTGACTGAG 3 * (Detection of a minor
HSAR11 5* CCTCTGCCCTTCAGACTAG 3 * human mRNA transcript)
HSAF12 5* AAACCCACATCAATTGCAC 3 * (5* region probe)
HSAF9 5* AGAACGGGCATTGTTATACAGG 3 * (Mapping, human SLN)
HPE1 5* TTTCTGAGGGCACACCAAGGACCTCTGGCTTG 3 * (Primer extension)
Cloning of rabbit SLN cDNA. Knowledge of the 45-bp sequence taining 50 ng of circularized BsiWI DNA was used as a template in
of rabbit SLN cDNA lying between primers SALF7 and SALR7 (Table an inverse PCR ampli®cation with primers SALF10 and SALR10
1) permitted the design of additional primers (SALF9, SALR9) for (Table 1). The PCR product of 1.1 kb was cleaved with BamHI,
inverse long PCR ampli®cation in which the cDNA and the whole cloned into Bluescript, and the sequence of the 5* end of human
pcDX vector sequence were included. PCR ampli®cation was carried SLN cDNA was determined. All eight clones analyzed started at
out with Taq polymerase:Pfu polymerase (5:1 ratio), using 100 ng of the A residue at position /6 of the cDNA sequence (Figs. 1B and
the full-length rabbit skeletal muscle cDNA library in pcDX as a 2). In addition, cDNA was reampli®ed with primers HSAF5 and
template. An initial hot start at 947C for 2 min preceded 30 cycles HSAR5 from human ®rst-strand cDNA, and the sequence of the
of denaturation at 947C for 30 s, annealing at 627C for 1 min, and 0.7-kb product was veri®ed by cycle sequencing.
elongation at 727C for 10 min. A single product of about 4.5 kb was Determination of the human SLN gene structure. Two primers at
puri®ed on a 1% agarose gel and extracted with a gel extraction kit both ends of the full-length cDNA (HSAF5 and HSAR5) were used
from Qiagen. About 10 ng of the product was then blunt ended by to amplify human genomic DNA. A single DNA product of 4.5 kb
incubation with 0.7 U/ml mung bean nuclease for 30 min at 377C; with a single intron in the 5* untranslated region of the cDNA was
the DNA was extracted with phenol and chloroform, precipitated, obtained. Flanking genomic DNA sequences were obtained by in-
and self ligated for 12 h at 127C using 5 U of T4 DNA ligase in a verse PCR, in which 4 mg of human genomic DNA was cleaved with
volume of 200 ml. Transformation of competent DH5a cells and selec- EcoRI, BglII, or HindIII, extracted with phenol and chloroform, pre-tion for ampicillin resistance conferred by the coampli®ed pcDX vec-
cipitated with 50% isopropanol containing 250 mM sodium acetate,tor yielded over 1000 colonies. The sequence of the full-length rabbit
washed once with 70% ethanol, and self ligated. The inverse longmuscle cDNA was determined using a T7 sequencing kit (Phar-
PCR ampli®cation used 50 ng of circularized DNA with a primermacia). To exclude any PCR cloning artifacts, rabbit SLN cDNA was
pair corresponding to the 5* (HSAF8, HSAR8) or the 3* (HSAF1,also ampli®ed with two oligonucleotides, RSAF7 and RSAR8 (Table
HSAR1) segments of the cDNA, respectively. For the 3* end, single1), using the pcDX library as a template. The sequence of the 0.7-
products of 5.7 and 3.5 kb were obtained from the BglII and HindIIIkb product was veri®ed by cycle sequencing.
circularized genomic DNA fragments, but no product was observed
Cloning of human SLN cDNA. The 3 * end of the human SLN when EcoRI circularized DNA was used as a template. For the 5*
cDNA was cloned by application of the 3 * RACE technique (Innis region, 5-, 4-, and 0.9-kb products were obtained for BglII, HindIII,
et al., 1990) in which 5 mg of total RNA from human skeletal muscle and EcoRI, respectively (Fig. 1A).was reverse transcribed with primer RACE1 (Table 1) as described
Primer extension. Total RNA was isolated from normal humanabove. Subsequent PCR ampli®cation with primers RACE3 and
skeletal muscle of two unrelated individuals as described above. TheHSAF1 using Taq polymerase:Pfu polymerase (5:1 ratio) yielded
oligonucleotides HSAR8 or HPE1 (Table 1) were labeled with poly-a single product of 550 bp, which was cleaved with BamHI and
nucleotide kinase and [g-32P]ATP to a speci®c activity of 300 nCi/ng.cloned into the Bluescript vector. Sequence analysis indicated that
Thirty micrograms of total RNA in 30 ml of hybridization buffer (40all eight clones analyzed were identical. The 5* end of human SLN
mM Pipes (1,4-piperazine-diethanesulfonic acid), pH 6.4, 1 mMcDNA was cloned by PCR ampli®cation from a lgt11 5* stretch
EDTA, 0.4 M NaCl, 80% formamide) was denatured for 5 min atcDNA library, kindly provided to us by Drs. Peter Ray and Perry
907C and annealed overnight at 307C with 3 ng of the labeled oligonu-Howard, Hospital for Sick Children, Toronto. Phage DNA was pre-
cleotide. The nucleic acids were ethanol precipitated, washed, andpared according to the l phage library protocol from Stratagene,
reverse transcribed as described above. The ®nal pellet was dissolvedin which 1 mg of lgt11 DNA is cleaved by BsiWI (which cuts at
both sides of the cDNA inserts) and self ligated. An aliquot con- in 4 ml of water, and 6 ml of formamide loading buffer was added.
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Three microliters of the product, corresponding to 10 mg of reverse
transcribed total RNA, was analyzed by electrophoresis on a 7.2%
denaturing polyacrylamide sequencing gel.
Northern blots. Northern blots, containing 8 mg of total RNA from
rabbit fast-twitch (psoas) and slow-twitch (soleus) skeletal muscle,
were prepared and treated as described by Ausubel et al. (1994).
Multiple tissue Northern (MTN) blots, loaded with 2 mg per lane of
poly(A)/ RNA derived from a number of human tissues, were pur-
chased from Clontech. A gel-puri®ed, 0.5-kb PCR fragment ampli®ed
with primers HSAF1 and HSAR5 from human cDNA and a 2-kb
human b-actin cDNA probe (Clontech) were labeled with [32P]dCTP
using random primers and T7 polymerase. Hybridization was carried
FIG. 1. (A) Structure and restriction map of human SLN. Theout for 1 h at 687C using ExpressHyb solution (Clontech) containing
upper line shows the restriction endonuclease map of the gene de-the labeled probe at a ®nal concentration of 5 ng/ml (1 1 106 CPM/
rived from clones obtained by PCR ampli®cation. Restriction endonu-ml). The MTN blots were subjected to autoradiography for 2, 16, and
clease sites are: E, EcoRI; B, BglII; H, HindIII. The locations of the72 h, at 0707C using Kodak b-max ®lm and two intensifying screens.
two exons within the gene (solid boxes) and the location of the codingThe blots were stripped and probed for b-actin mRNA according to
sequence within exon 2 (white box) are indicated on the lower line.the protocol of the manufacturer. Autoradiography was for 4 h.
The positions of the TATA and CCAAT sequences, the ATG initiation
Southern blots. Multiple species Southern (Zoo) blots, loaded codon, and polyadenylation signal sequences are marked. (B) Nucleo-
with 4 mg of genomic DNA cleaved with the restriction endonuclease tide and deduced amino acid sequences of human SLN. Upstream
EcoRI, were purchased from Clontech and hybridized according to nucleotides, in lowercase, are numbered negatively, on the left, to
the instructions of the manufacturer. Either the 0.5-kb HSAF1- the transcription initiation site. Exon sequences are in uppercase and
HSAR5 probe, speci®c for exon 2 (described above), or the 350-bp numbered positively thereafter. The sequence of the single intron is
probe obtained with primers HSAF12 and HSAR8, speci®c for the presented in lowercase and is not numbered. Numbers relative to
5* region of the SLN gene, was used. The blot was washed at low the cDNA at the ends of both exons are in parentheses below the
stringency (21 SSC, 0.05% SDS; 607C). sequence. Putative DNA binding elements for eukaryotic transcrip-
Chromosomal mapping of the SLN gene. To determine the chro- tional factors are underlined and identi®ed below the sequence. The
mosomal localization of the SLN gene, a 4.5-kb, PCR-ampli®ed geno- GenBank accession number for these sequences are U96092±
mic DNA fragment (HSAF5 and HSAR5) was used for ¯uorescence U96094.
in situ hybridization (FISH) experiments. FISH was performed fol-
lowing the procedure of Lichter et al. (1990), by counterstaining the
chromosomes with propidium iodide and DAPI. The biotinylated ®cation and cycle sequencing were performed as described by Oder-
probe was detected with avidin±FITC. Images of metaphase prepa- matt et al. (1996).
rations were captured by a thermoelectrically cooled, charge-coupled Case histories. Brody patients F3P3, F4P3, and F5P3 were de-
camera (Photometrics, Tucson, AZ). Separate images of DAPI- scribed as patients 1±3 in Zhang et al. (1995). Patient F3P3 was also
banded chromosomes (Heng and Tsui, 1993) and of FITC-targeted described as patient 1 in Karpati et al. (1986). Patient F6P3 had a
chromosomes were obtained. Hybridization signals, pseudocolored long history of exercise- and cold-induced muscle stiffness, pain, and
yellow for FITC and pseudocolored blue for DAPI-stained chromo- cramps. Treatment with Verapamil produced impressive improve-
somes, were overlaid electronically and merged using Adobe Pho- ment in his symptoms. His mother and sister were said to suffer
toshop 3.0 software. The band assignment was determined by mea- from similar symptoms, suggesting dominant inheritance of the dis-
suring the fractional chromosome length and by analyzing the band- ease. No myotonia was observed either clinically or on electrophysio-
ing pattern generated by the DAPI counterstained image. logical testing. Creatine kinase was mildly elevated. Ischemic exer-
The chromosomal localization of the SLN gene was con®rmed by cise testing showed normal elevation of serum lactate and ammonia.
screening the NIGMS somatic cell hybrid panel 2 (Dubois and A muscle biopsy showed nonspeci®c, mixed myopathic and neuro-
Naylor, 1993) and the GeneBridge 4 radiation hybrid (RH) panel pathic features. Patient F7P3 was described as patient 6 in Benders
(Walter et al., 1994), purchased from Research Genetics. Radiation et al. (1994).
hybrid mapping experiments were carried out in duplicate and the
data were analyzed at a lod score of 3.0 using the RH server from
the Whitehead Institute/MIT Center for Genomic Research. The RESULTS
primers used for this speci®c analysis were HSAF9 and HSAR11
(Table 1), which ampli®ed a 900-bp human-speci®c band using the
Characterization of the Human SLN Genefollowing conditions: denaturation at 947C for 30 s; annealing at 627C
for 2 min; extension at 727C for 2 min, for 35 cycles. The complete set
Figure 1A shows the structure and restriction mapof RH data is available through the NCBI radiation hybrid mapping
service at http://www.ncbi.nlm.gov/SCIENCE96/. of human SLN, and Fig. 1B provides a partial DNA
Analysis of mutations in ATP2A1 of patients from Brody families sequence of the human SLN gene. The partial sequence
BD3 and BD6. Genomic DNA was ampli®ed, and the 23 ATP2A1 includes: 967 bp of the 5* region containing the proba-
exons, plus 1500 bp upstream of the transcription initiation site ble promoter of the SLN gene, nuceotides 0967 to 01;
containing the putative promoter region, were sequenced, as de- exon 1 nucleotides /1 to /99, which form part of thescribed by Odermatt et al. (1996). At least 30 bp of ¯anking sequence
5* untranslated region of the cDNA; about 300 bp ofwas determined for each exon.
sequence at both the 5* and the 3 * ends of the singleAnalysis of SLN sequence in patients of Brody families BD3 (F3)
to BD7 (F7). Muscle biopsies were available from Brody patients 3.9-kb intron; exon 2 nucleotides /100 to /719, which
F4P3 and F5P3 (Table 2). First-strand cDNA, prepared as described form the remainder of the 5* untranslated region, the
above, was ampli®ed with primers HSAF5 and HSAR5, and the se- coding sequence for SLN, and the 3 * untranslated re-
quence of the 0.7-kb product was determined by cycle sequencing. gion of the SLN gene; and 556 bp of downstream se-Genomic DNA was isolated from blood from patients F3P3, F6P3,
quence. Primer extension analysis using total RNA iso-and F7P3, using the Qiaamp blood kit (Qiagen). A 5-kb DNA frag-
ment was ampli®ed with primers HSAF12 and HSAR11. PCR ampli- lated from skeletal muscle of an individual with no
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tide /719 in Fig. 1B. The total length of the gene is
about 5.6 kb.
A search for potential DNA binding elements for
known eukaryotic transcriptional factors revealed a
cluster of three possible TATA box sequences between
0745 bp and 0783 bp (Fig. 1B). Two additional TATA
boxes were found between 0945 and 0949 bp and be-
tween 0633 and 0636 bp. A CCAAT box was found 45
bp downstream of the TATA box cluster between 0700
and 0704 bp. The CCAAT box of the SLN gene, CTC-
CCAATCT, differed from the consensus sequence GGY-
CCAATCT (Lewin, 1994) in having pyrimidines rather
than purines upstream of the YCCAATCT sequence.
Several E box sequences (CANNTG), recognized by the
MyoD family of basic helix±loop±helix transcriptional
activators (Piette et al., 1990; Weintraub et al., 1990),
were identi®ed in the 5* region of the SLN gene. One
pair of E boxes, separated by 11 bp and lying between
0587 and 0609 bp, and a second pair of E boxes, sepa-
rated by 10 bp and lying between 0198 and 0219 bp,
were located downstream of the CCAAT box. In addi-
tion, a potential binding site for the myocyte enhancer
factor MEF-2 (CTA(A/T)4TAG) was identi®ed upstream
of the TATA box cluster between 0805 and 0814 bp.
The sequence CTTGGTTACAA, with similarity to the
MEF-3 enhancer element (TCAGGTTT(T/A)CA) de-
scribed by Hidaka et al. (1993), was found just up-
stream of the MEF-2 motif between 0828 and 0838
bp. An additional MEF-3-like motif (TCAGTTTTGAA)
was found between 0497 and 0505 bp. Unlike the
MEF-3 consensus sequence, the motifs found in the
SLN gene had palindromic ends. We identi®ed a possi-
ble site for the transcriptional activator protein AP-
FIG. 1ÐContinued
history of genetic disease was carried out to determine
the transcription initiation site. A single product was
generated using primer HSAR8 (complementary to a FIG. 2. Primer extension. 10 mg of total RNA from normal human
sequence within exon 1; Fig. 2) or HPE1 (complemen- skeletal muscle of control individuals 1 (lane 1) or 2 (lane 2) were
reverse transcribed using 32P-labeled oligonucleotide HSAR8. (A, C,tary to a sequence within exon 2; not shown). The SLN
G, T) Sanger sequencing reactions with the same primer. The reac-transcription initiation site was assigned to an A resi-
tion products were resolved on a 7.2% DNA sequencing gel, anddue 175 bases upstream from the translation initiation radioactivity was visualized by autoradiography. The relevant DNA
site in mRNA (/1 in Figs. 1B and 2). The polyadenyla- sequence is given on the right. The transcription initiation site is
indicated by an asterisk.tion site in the major transcript was located at nucleo-
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FIG. 3. (A) Alignment of human, rabbit, and mouse SLN nucleotide and deduced amino acid sequences. The ®rst 11 nucleotides, in
lowercase, form part of the translation initiation sequence (Kozak, 1987), while the nucleotides in uppercase indicate coding sequences.
Stop codons are italicized. Nucleotides and amino acids deviating from the consensus sequence are underlined and boldface. (B) Comparison
of charge distribution in the hydrophilic, N-terminal domain of human, rabbit, and mouse SLN.
1 (Lee et al., 1987) between 0341 and 0348 bp. The The human sequences were obtained by similar meth-
translation initiation signal sequence (Kozak, 1987) at ods, as outlined under Materials and Methods. Se-
the end of the promoter sequence (GCTGTGAAA- quences from mouse cardiac and skeletal muscle SLN
ATGG) is reasonably conserved compared to the con- were obtained from a computer search of the GenBank
sensus sequence (GCCGCCA/GCCATGG). EST database, which also identi®ed human SLN EST
Sequencing of the 3 * end of the human SLN gene sequences (Washington University School of Medicine±
revealed the major polyadenylation signal, AATAAA, Merck EST project) covering most of the full-length
between nucleotides 701 and 706, with polyadenylation cDNA, but lacking the 5* and 3 * tails.
occurring after residue 719. A potential polyadenyla- Comparison of human, rabbit, and mouse SLN
tion signal sequence, AATAAA, was also found 252 bp cDNAs revealed 84% nucleotide sequence identity be-
downstream of the major polyadenylation signal se- tween human and rabbit, 44% nucleotide sequence
quence. To test whether this downstream polyadenyla- identity between human and mouse, and 41% nucleo-
tional signal was used, PCR analysis was carried out tide sequence identity between mouse and rabbit SLN
with a forward primer (HSAF3) in exon 1 and a reverse cDNAs. The higher level of nucleotide sequence iden-
primer (HSAR11) at the downstream poly(A)/ site. Hu- tity between the human and rabbit SLN cDNAs is re-
man skeletal muscle ®rst-strand cDNA primed with ¯ected in their identical length and in their use of the
oligo(dT) was used as a template. A product of 660 bp same polyadenylation signal sequence for the major
was ampli®ed (not shown), indicating that the longer transcript, 14 bp upstream of the poly(A)/ tail. This
transcript was, indeed, synthesized. Contamination by polyadenylation site is lacking in the mouse SLN ESTs,
genomic DNA was excluded on the basis of the absence which contain a consensus polyadenylation signal se-
of intronic sequence in the PCR product. We estimate quence 150 bp further downstream, with polyadenyla-that the level of the longer transcript was less than 5% tion occurring an additional 100 bp downstream. Theof that of the major 719-bp transcript. There was no
length of the mouse SLN cDNA is at least 950 bp. Anindication of the use of a potential polyadenylation sig-
AUUUA motif that could act as an RNA degradationnal sequence, AATTAA, 158 bp upstream of the major
signal (Shaw and Kamen, 1986) is present in the majorsignal sequence.
transcript of human and rabbit mRNA, about 250 bp
downstream of the stop codon, but is lacking in the
Isolation and Analysis of cDNA Clones Encoding mouse transcript. Another potential polyadenylation
Rabbit and Human SLN signal sequence, present in all three species, is located
50 bp downstream of the potential RNA degradationNucleotide sequence. Figure 3 illustrates the nucle-
signal. The ®rst 11 nucleotides, which include theotide sequences encoding human, rabbit, and mouse
translation initiation signal sequence (Kozak, 1987),SLN and their deduced amino acid sequences. The rab-
are not well conserved among the three species.bit sequences were con®rmed in eight clones obtained
Amino acid sequence. The SLN gene encodes a pro-from a cDNA library by circularization, following in-
verse long PCR ampli®cation from primers in exon 2. tein of 31 amino acids that can be divided into three
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SLN transcript was found in rabbit fast-twitch skeletal
muscle (psoas) than in slow-twitch skeletal muscle (so-
leus) (Fig. 5C).
Multiple-Species Genomic DNA Analysis
FIG. 4. Alignment of human SLN and PLN peptide sequences.
Amino acids 23 to 52 of human PLN are shown in the upper line. A Southern blot containing genomic DNA from nine
The lysine at position 27 of human PLN is replaced by an asparagine eukaryotic species, digested with restriction endonucle-in PLN of rabbit, dog, and pig (above). The peptide sequence of hu-
ase EcoRI, was probed with a 350-bp, PCR-ampli®edman SLN is shown in the lower line. Amino acids different in rabbit
DNA fragment from the 5* exon 1-containing region ofor mouse are indicated beneath. The vertical lines in the alignment
indicate identical amino acids, whereas conserved amino acids are the SLN gene (Fig. 6). A single band was detected in
shown by two vertical dots. The asterisk indicates the ®rst and last genomic DNA from each of human (0.9 kb), monkey
amino acid of the predicted transmembrane helix of SLN. (0.95 kb), dog (1.5 kb), cow (1.05 kb), and rabbit (4.4
kb). The size of 0.9 kb of the EcoRI-digested human
domains: a hydrophilic N-terminal domain of 7 amino genomic DNA fragment con®rmed the ®nding of a 0.9-
acids; a hydrophobic, transmembrane helical domain kb DNA product obtained by inverse PCR ampli®cation
of 19 amino acids; and a hydrophilic C-terminal domain with primers speci®c for the 5* region of the SLN gene.
consisting of 5 amino acids. Neither the hydrophilic N- Genomic DNA from chicken yielded two bands of 1.6
terminal sequences nor the hydrophobic transmem- and 2.6 kb. The hybridization signal of the human
brane sequences are well conserved among the three probe with mouse and rat genomic DNA was very weak,
species studied, and changes in net charge occur in re¯ecting the fact that there is much lower similarity
the N-terminal sequences. The hydrophilic C-terminal between human and mouse SLN cDNAs than between
sequences are, however, perfectly conserved. The human and rabbit SLN cDNAs. No hybridization to
amino acid sequence of the rabbit protein, deduced digested yeast genomic DNA was observed. A similar
from the cDNA, is identical to the peptide sequence pattern was obtained using a labeled probe speci®c for
determined by Wawrzynow et al. (1992). the 3 * region of the SLN gene (not shown).
The SLN sequence from residue 4 to residue 26 (4
N-terminal hydrophilic residues and 19 hydrophobic Chromosomal Localization
transmembrane residues) shares a striking similarity
To determine the location of the SLN gene, we per-with residues 28 to 49 of PLN (Fig. 4). This similarity
formed FISH using a 4.5-kb, PCR-ampli®ed DNA probebecomes more evident if alternate residues at different
covering both exons and the single intron. Positive sig-points in the sequences of the three species are consid-
nals were observed on both chromosome 11 chromatidsered. Asn4 in human SLN corresponds to Asn27 in PLN
in the region of 11q22±q23. No hybridization to anyin rabbit, pig, and dog. Gln6 in mouse SLN corresponds
other chromosome was observed. The assignment ofto Gln29 in human PLN. At human SLN positions 10,
the SLN gene to human chromosome 11 was con®rmed20, and 22 Leu, Ile, and Met differ from the correspond-
using monochromosomal rodent±human somatic celling residue in human PLN, but in other species, corre-
hybrids. To re®ne the position of the gene on the geneticspondence of one or more of these residues is observed.
and physical map of 11q, we screened the GeneBridgeOn the basis of these sequence similarities, we propose
4 RH panel. The results indicate that SLN is ¯ankedthat SLN and PLN are homologous proteins. Since the
by the two genetic markers CHLC.GATAGC11 andorientation of PLN in the membrane is well estab-
CHLC.GATA71E06. SLN was 7.04 cR from the formerlished, we propose that the N-terminal domain of SLN
marker. Although this entire region appears to be cov-is cytosolic and that the C-terminal domain faces the
ered by a set of overlapping YACs (Hudson et al., 1995),lumen of the sarcoplasmic reticulum.
our analysis failed to detect a positive clone for the
SLN gene from this collection. Nevertheless, the FISHCharacterization of SLN Expression
and RH data are consistent, indicating that the gene
The distribution of SLN mRNA in various human maps to human chromosome 11q22±q23.
tissues was determined by Northern blot analysis us-
ing a PCR-ampli®ed probe from the 3 * untranslated Sequencing of SLN from Patients of Brody Families
region of the cDNA that hybridized to a single tran- BD3 to BD7
script of 0.7 kb (Fig. 5). This SLN transcript was highly
expressed in skeletal muscle, but was at least 50-fold No mutations were found in the sequence of the SLN
cDNA ampli®ed from patients F4P3 (recessive inheri-less abundant in heart muscle, as determined by densi-
tometry of the exposed ®lm. Only trace amounts were tance, Table 2) or F5P3 (dominant inheritance), nor were
any mutations found in the sequence of the SLN genedetected in prostate and pancreas. In all other tissues
analyzed (brain, placenta, lung, liver, kidney, uterus, ampli®ed from genomic DNA from patients from families
BD3 (recessive), BD6 (dominant), or BD7 (dominant) (Ta-colon, small intestine, bladder, and stomach), no SLN
transcript was detected. A 9-fold higher level of the ble 2). Genomic sequences included each of the two exons
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FIG. 5. Analysis of SLN gene expression. Human multiple tissue Northern (MTN) blots (Clontech) containing: (A) mRNA from heart,
brain, placenta, lung, liver, skeletal muscle, kidney, and pancreas; and; (B) skeletal muscle, uterus (no endometrium), colon (no mucosa),
small intestine, bladder, heart, stomach and prostate (top) were probed with a 0.5-kb PCR product (HSAF1±HSAR5) derived from human
SLN cDNA. The positions of RNA size markers (kb) are indicated on the left. Autoradiography was carried out for 16 h at 0707C. (Bottom)
The same blots were probed with a human b-actin cDNA and exposed for 4 h. The second hybridization signal at 1.6±1.8 kb observed in
both heart and skeletal muscle is due to probe hybridization to either the a or the g form of actin (Giovanna et al., 1991; Lamballe et al.,
1991). (C) Analysis of SLN expression in rabbit fast-twitch and slow-twitch skeletal muscle. The Northern blot was probed with the 0.7-
kb RSAF7±RSAR8 PCR product, speci®c for rabbit SLN mRNA. Autoradiography was for 6 h.
and at least 100 bp of intron sequence ¯anking each exon Sequencing of ATP2A1 from Genomic DNA of
and 850 bp of the proposed promoter region. The substitu- Patients F3P3 and F6P3
tion of G for C11 in the 5* untranslated region of exon 2
was detected in patient F3P3. The insertion of a T in Sequence analysis of ATP2A1 from genomic DNA of
both alleles at position 0118 was observed in patient patient F6P3 (dominant) did not reveal any mutations
F6P3. This mutation did not affect the structure of SLN in the putative promoter region, in the two exons, or
and was not considered signi®cant. in 10±100 bp of intronic sequence ¯anking each exon.
The substitution of T for C678, a polymorphism that
does not change the amino acid sequence (Zhang et al.,
1995), was detected in patient F6P3.
The fact that no detectable defect in either SLN or ATP-
2A1 (Zhang et al., 1995) had been found in patient F3P3
(recessive), who had been reported to be devoid of SERCA1
(Karpati et al., 1986), led us to a reexamination of ATP2A1
in this patient and his brother (patient 2 in Karpati et al.,
1986). Haplotyping of the region surrounding ATP2A1 as
described by Odermatt et al. (1996) showed that these
brothers had the identical haplotype on both chromo-
somes, indicating homozygosity in this region (not shown).
The fact that the parents in this family were ®rst cousins
is consistent with this degree of homozygosity.
Resequencing of ATP2A1 from patient F3P3 showed
the presence of the T for C678 polymorphism noted
earlier (Zhang et al., 1995), but this time the deletion
FIG. 6. Southern blot analysis of the SLN gene. A multiple spe- of a C in a series of three Cs (cDNA nucleotides 437
cies Southern blot (Clontech) was probed with the 350 bp HSAF12± to 439) was detected (Fig. 7). This deletion led to aHSAR8 PCR product, speci®c for the 5* region of the human SLN
homozygous frame shift at Pro147, which would lead togene, and washed under low-stringency conditions (607C: 21 SSC,
0.05% SDS). Positions of DNA size markers are indicated on the left. a stop codon in both transcripts after the incorporation
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TABLE 2
Analysis for Mutations in ATP2A1 and SLN of Brody Families
Family Patient ATP2A1 SLN Inheritance Reference
BD1 F1P3, F1P4 Homozygous Arg198 to Stop n. d. Recessive F1P3,a P4b
BD2 (F2P1),c F2P3, F2P4 Cys675 to Stop, and intron n. d. Recessive F2P3,a P3d
(F2P2),e F2P3, F2P4 3 splice donor GT to CT
(compound heterozygote
BD3 F3P3, F3P4 Homozygous deletion of a C No mutation Recessive P1,d P1f
frameshift at Pro147
BD4 F4P3 No mutation No mutation Recessive P2f
BD5 F5P3 No mutation No mutation Dominant P3f
BD6 F6P3 No mutation No mutation Dominant
BD7 F7P3 n. d. No mutation Dominant P6b
a Odermatt et al. (1996).
b Benders et al. (1994).
c Unaffected father.
d Karpati et al. (1986).
e Unaffected.
f Zhang et al. (1995).
of 33 additional amino acids. This mutation is very the cDNA is present in our pcDX library, as described
here, and is present in other libraries from both skele-similar to the two cases of ATP2A1-linked Brody dis-
ease described earlier (Odermatt et al., 1996) in that tal and cardiac muscle (Washington School of Medi-
cine±Merck EST project, GenBank). In this study, wemutations in both alleles led to premature termination
codons and to truncation of SERCA1. In three of four cloned the SLN gene from our full-length rabbit skele-
cases of autosomal recessive inheritance of Brody dis- tal muscle cDNA library in the pcDX vector by a novel
ease described to date, SERCA1 protein has been lost application of inverse long PCR. In this method, the
due to these truncations (Table 2). Our results suggest vector sequence, containing an antibiotic resistance
that mutations in ATP2A1, leading to a predicted func- marker, was coampli®ed with the full-length cDNA,
tional knock-out of SERCA1, account for the majority allowing us to self-ligate the PCR product and use the
of autosomal recessive forms of Brody disease, but not circularized DNA directly for transformation of compe-
for dominant forms of the disease. tent bacterial cells. Since self-ligation was very ef®-
cient, as little as 1 ng of circularized PCR product was
suf®cient for successful cloning. By inverse long PCR,DISCUSSION
products up to 8 kb in length have been obtained. Ac-
cordingly, this method has potential application for di-Cloning of Rabbit and Human SLN by Application
rect cloning of even very long cDNAs inserted into vec-of Inverse Long PCR Several earlier attempts in our
tors of the usual length of about 4 kb. For example, welaboratory to clone SLN by hybridization screening of a
skeletal muscle library were unsuccessful, even though have successfully cloned full-length ATP2A1 cDNAs of
FIG. 7. Analysis of the deletion of one of the three Cs in nucleotide positions 437, 438, and 439, numbered according to the cDNA
sequence of the ATP2A1 gene encoding SERCA1 (Zhang et al., 1995), in family BD3. PCR ampli®ed ATP2A1 genomic DNA was sequenced,
and the deletion of one of the three Cs at Nucleotides 437, 438, or 439, leading to a frameshift beginning with the codon for Pro147, is
indicated by an arrow. The effect of the mutation on amino acid sequences is shown beneath. The G-track and the nucleotide sequences of
the homozygous mutant DNAs of the two affected brothers, F3P3 and F3P4, and two unrelated control DNAs, C1 and C2, are indicated.
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3.5 kb from our pcDX library. The use of Pfu polymer- served hydrophobic transmembrane sequence, and per-
fect conservation of the C-terminal hydrophilicase to avoid PCR artifacts is strongly recommended.
We also applied inverse long PCR to a human skele- sequence, which, by analogy with the well-character-
ized structure of phospholamban (Fujii et al., 1991),tal muscle 5* stretch cDNA library in lgt11 to clone
human SLN. The phage DNA was digested with an should lie in the lumen of the sarcoplasmic reticulum.
The functional consequences of the different charge dis-enzyme ¯anking the cDNA at both sides, and the circu-
larized DNA was used as a template for inverse long tribution in the cytoplasmic domain of SLN in the three
species are not clear. By contrast, SERCA1, with whichPCR. The disadvantage of using phage library tem-
plates is the lack of a selectable marker on the ampli- SLN seems to interact, is highly conserved between
rabbit and human (Zhang et al., 1995). The low level®ed product. Accordingly, it is necessary to recover
much higher yields of the PCR product for cloning into of conservation of the SLN cDNA between different
species is also re¯ected in the weak hybridization sig-a plasmid vector.
nal obtained on a Zoo blot using a human SLN probe.
5* Upstream Region of the Human SLN gene One or two main bands were detected in all species
tested, except yeast (Fig. 6).In the SLN gene, a cluster of three TATA box ele-
ments is located about 40 bp upstream of a CCAAT
Relationship between SLN and PLN Genesbox, which, in turn, is found 700 bp upstream of our
proposed transcriptional start site. A similar unusual The human SLN and PLN (Fujii et al., 1991) genesarrangement of CCAAT and TATA box elements was share common features, consistent with their origin indescribed for the skeletal muscle RYR1 gene (Phillips a common ancestor. Both genes contain two exons andet al., 1996), with a CCAAT sequence 68 bp upstream one intron. In both cases, the intron is located aboutof the transcription initiation site and a cluster of ®ve 90 bp downstream of the transcription initiation site,TATA box elements a further 1500 bp upstream. A and in both cases it interrupts the 5* untranslated se-binding site for the myocyte enhancer factor, MEF2, in quence, so that the entire coding sequence is located incombination with a MEF3-like element, follows just exon 2. The introns are relatively large, about 3.9 kbupstream of the TATA box cluster in the SLN gene. long in SLN and about 6 kb long in PLN. The 3 * endsThe muscle-speci®c induction of the aldolase A gene of both genes contain multiple polyadenylation signals,has been shown to be controlled through cooperation and more than one polyadenylation site is used in bothbetween the muscle-speci®c factor MEF2 and the more genes (Fujii et al., 1988). Alignment of human SLNubiquitous factor MEF3 (Hidaka et al., 1993). An addi- and PLN cDNA reveals 60% nucleotide identity in thetonal MEF3-like site is located 200 bp downstream of region encoding the predicted transmembrane helices,the CCAAT box in the SLN gene. The 5* region of the even though only 30% identity is observed for the N-SLN gene contains several E boxes (CANNTG). E terminal and C-terminal domains (not shown).boxes, which are recognized by the MyoD family of ba- On the basis of the conservation of amino acids insic -helix±loop±helix transcriptional activators, occur parts of the N-termini and much of the transmembraneby chance every 250 bp in DNA sequences. However, helices of SLN and PLN, we propose that SLN andMyoD has been shown to bind cooperatively to paired PLN are homologous proteins. It is possible that theysites with a 19-bp space in the muscle creatine kinase have achieved this degree of sequence identity by con-enhancer (Weintraub et al., 1990) and to paired sites vergent evolution, but, in light of the similarity in genewith a 12-bp space in the acetylcholine receptor a-sub- structure, it seems much more likely that sequenceunit enhancer (Piette et al., 1990). In the SLN gene, similarity is based on divergent evolution from a com-two E box pairs with 11 and 10 bp space between both mon gene.E boxes follow about 200 and 500 bp downstream of The differences in the N- and C-terminal sequencesthe CCAAT box. These DNA binding elements might of SLN and PLN must re¯ect their different interac-be responsible for the muscle-speci®c expression of the tions with different cytoplasmic proteins (PLN is phos-SLN gene revealed by Northern analysis. In contrast phorylated by protein kinase A, but SLN is not), butto the ATP2A1 gene (Korczak et al., 1988) and the their conserved transmembrane sequences suggest re-RYR1 gene (Phillips et al., 1996), Sp1 sites and the tention of the ability to interact with conserved trans-proposed muscle-speci®c promoter element GGC- membrane sequences in other proteins. The threeTGGGG are absent from the SLN promoter region. SERCA molecules (Burk et al., 1989) are the most likely
candidates for such interactions. PLN is coexpressedConservation of SLN in Different Species
with SERCA2a and interacts functionally with it. PLN
also retains the capacity to inhibit SERCA1 (ToyofukuAlignment of amino acid sequences of SLN from hu-
man, rabbit, and mouse (this study; Washington School et al., 1993), but does not do so because the two proteins
are not coexpressed in the same tissue. SLN is mostof Medicine±Merck EST project, GenBank; Wawrzy-
now et al., 1992) revealed poor conservation of the hy- highly expressed in fast-twitch muscle, where SERCA1
is highly expressed and the two proteins copurify (Mac-drophilic N-terminal sequence, a relatively well-con-
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Lennan et al., 1972). In our most recent in vitro coex- gain inhibitory function leading to the morbidity asso-
ciated with a highly inhibited form of SERCA1, we ini-pression experiments, we have found that SLN inhibits
SERCA1 by decreasing its apparent af®nity for Ca2/ tiated a search for SLN mutants in the four Brody fami-
lies with non-ATP2A1-linked Brody disease and with(A. Odermatt, S. Becker, V. K. Khanna, K. Kurzydlow-
ski, and D. H. MacLennan, unpublished). Since PLN a ®fth family available to us. Unfortunately, we did
not ®nd any alterations that would support SLN as ainhibits the activity of SERCA2a by decreasing its ap-
parent af®nity for Ca2/, SLN may act as the counter- candidate gene for Brody disease in these ®ve families.
In additional studies of BD, we showed that twopart of PLN in fast-twitch skeletal muscle.
Transmembrane helices M4, M5, and M6, which are brothers in family BD3, in which ATP2A1 mutations
had not been found in an earlier study (Zhang et al.,key to Ca2/ binding and translocation in SERCA1 (Rice
and MacLennan, 1996), are highly conserved in all 1995), shared a common haplotype on chromosome
16p12.1±p12.2, suggesting the need for reevaluation ofthree SERCA molecules. Thus the three transmem-
brane sequences in SERCA molecules and the single the role of the ATP2A1 gene in the disease. This led us
to resequence ATP2A1 in this family and to the discov-transmembrane sequence in SLN/PLN molecules may
have coevolved, conferring a degree of evolutionary sta- ery of a fourth BD mutation that would truncate
SERCA1. Currently four mutations in three BD fami-bility on each other. The cytoplasmic domain of PLN
also interacts with a cytoplasmic domain of SERCA2a lies are known, all resulting in recessive inheritance of
BD. The only recessive BD family that has not been(Toyofuku et al., 1994). This site is conserved in SER-
CA1, but is missing from SERCA3. shown to have an ATP2A1 mutation is BD4 (Table 2).
We are currently haplotyping two brothers in this fam-The SLN gene is expressed most abundantly in fast-
twitch skeletal muscle (Fig. 5C), the tissue in which ily to determine whether resequencing of ATP2A1
might be warranted. In three other BD families whereSERCA1 is expressed almost exclusively. This is also
the tissue from which SLN was ®rst isolated, in associ- inheritance is dominant (Table 2), the causal gene has
yet to be discovered.ation with highly puri®ed SERCA1 (MacLennan et al.,
1972). Like SERCA1 expression (Wu and Lytton, 1993), SLN localizes to human chromosome 11q22±q23, a
region frequently deleted in several hematological ma-SLN expression is 10 times lower in slow-twitch skele-
tal muscle (soleus) than in fast-twitch skeletal muscle lignancies. In acute leukemias, the MLL (ALL1, HRX,
and HTRX) gene, which maps to 11q23, is involved in(WST, EDL). In cardiac tissue, the concentration of the
SLN transcript is about 50-fold less abundant than it is reciprocal translocations with a large number of gene
partners (Bernard and Berger, 1995). Leukemias mani-in skeletal muscle (Fig. 5A). SLN expression is another
order of magnitude lower in pancreas and prostate (Fig. festing 11q23 rearrangements have been shown to be
associated with very poor prognosis (Rasio et al., 1996).5B), where SERCA2b predominates. PLN is expressed
most abundantly in cardiac and slow-twitch skeletal This region also seems to be sensitive to DNA topoisom-
erase II inhibitors, as the majority of therapy-relatedmuscle, where SERCA2a is the predominant SERCA
molecule, and at much lower levels in fast-twitch skele- leukemias resulting from treatment with these inhibi-
tors demonstrate MLL rearrangements (Canaani et al.,tal muscle and smooth muscle (Fujii et al., 1988). Thus
SLN and PLN are expressed in muscle-speci®c and 1995). Cultured cells harboring such deletions might
provide an interesting experimental system for the in-complementary patterns, and the patterns of their ex-
pression are directly correlated with the expression of vestigation of the function of SLN in cell physiology.
different SERCA molecules in each muscle tissue. On
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